Skip to main content
. 2019 Dec 30;9:20329. doi: 10.1038/s41598-019-56861-6

Figure 1.

Figure 1

Effects of oral administration of KAG-308 in surgically induced mouse knee osteoarthritis (OA). (a) Schematic representation of the surgical procedure for OA induction, oral administrations, and time of sacrifice. Oral treatments were performed once a day from the day after surgery for 8 wks. Quantification of OA development using the Osteoarthritis Research Society International (OARSI) score for (b) the first experiment (n = 5 in the vehicle group and n = 4 in the KAG-308 group) and (c) the follow-up experiment as a confirmatory phase (n = 13 in the vehicle group and n = 12 in the KAG-308 group). Symbols represent individual mice; long and short bars show the mean and SD, respectively. *P < 0.005 by Welch’s t test. (d) Representative safranin-O staining from vehicle and 3 mg/kg KAG-308 groups. Scale bar, 100 µm.